129 related articles for article (PubMed ID: 2047545)
1. Pancreastatin-like immunoreactivity in human carcinoid disease.
McGrath-Linden SJ; Johnston CF; O'Connor DT; Shaw C; Buchanan KD
Regul Pept; 1991 Mar; 33(1):55-70. PubMed ID: 2047545
[TBL] [Abstract][Full Text] [Related]
2. The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system.
Bishop AE; Bretherton-Watt D; Hamid QA; Fahey M; Shepherd N; Valentino K; Tatemoto K; Ghatei MA; Bloom SR; Polak JM
Mol Cell Probes; 1988 Sep; 2(3):225-35. PubMed ID: 2851738
[TBL] [Abstract][Full Text] [Related]
3. Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues.
Schmidt WE; Siegel EG; Lamberts R; Gallwitz B; Creutzfeldt W
Endocrinology; 1988 Sep; 123(3):1395-404. PubMed ID: 3042370
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients.
Syversen U; Mignon M; Bonfils S; Kristensen A; Waldum HL
Acta Oncol; 1993; 32(2):161-5. PubMed ID: 8323758
[TBL] [Abstract][Full Text] [Related]
5. High plasma pancreastatinlike immunoreactivity in a patient with malignant insulinoma.
Tateishi K; Funakoshi A; Jimi A; Funakoshi S; Tamamura H; Yajima H; Matsuoka Y
Gastroenterology; 1989 Nov; 97(5):1313-8. PubMed ID: 2551767
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A(210-301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors.
Woussen-Colle MC; Lingier P; Vertongen P; Vandermeers-Piret MC; Vandermeers A; Robberecht P
Peptides; 1994; 15(5):869-74. PubMed ID: 7984507
[TBL] [Abstract][Full Text] [Related]
7. Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay.
Bishop AE; Hamid QA; Adams C; Bretherton-Watt D; Jones PM; Denny P; Stamp GW; Hurt RL; Grimelius L; Harmar AJ
Cancer; 1989 Mar; 63(6):1129-37. PubMed ID: 2645037
[TBL] [Abstract][Full Text] [Related]
8. Distribution and partial characterisation of immunoreactivity to the putative C-terminus of rat pancreastatin.
Curry WJ; Johnston CF; Shaw C; Buchanan KD
Regul Pept; 1990 Oct; 30(3):207-19. PubMed ID: 2259750
[TBL] [Abstract][Full Text] [Related]
9. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A.
Schmidt WE; Siegel EG; Kratzin H; Creutzfeldt W
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8231-5. PubMed ID: 3186720
[TBL] [Abstract][Full Text] [Related]
10. Pancreastatin distribution and plasma levels in the pig.
Bretherton-Watt D; Ghatei MA; Bishop AE; Facer P; Fahey M; Hedges M; Williams G; Valentino KL; Tatemoto K; Roth K
Peptides; 1988; 9(5):1005-14. PubMed ID: 3244555
[TBL] [Abstract][Full Text] [Related]
11. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
12. Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour.
Curry WJ; Shaw C; Johnston CF; Thim L; Buchanan KD
FEBS Lett; 1992 Apr; 301(3):319-21. PubMed ID: 1577173
[TBL] [Abstract][Full Text] [Related]
13. Plasma pancreastatin-like immunoreactivity in various diseases.
Tateishi K; Funakoshi A; Wakasugi H; Iguchi H; Shinozaki H; Abe M; Funakoshi S; Tamamura H; Yajima H; Matsuoka Y
J Clin Endocrinol Metab; 1989 Dec; 69(6):1305-8. PubMed ID: 2555388
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a tumor-derived human protein related to chromogranin A and its in vitro conversion to human pancreastatin-48.
Tamamura H; Ohta M; Yoshizawa K; Ono Y; Funakoshi A; Miyasaka K; Tateishi K; Jimi A; Yajima H; Fujii N
Eur J Biochem; 1990 Jul; 191(1):33-9. PubMed ID: 2165909
[TBL] [Abstract][Full Text] [Related]
15. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia.
Syversen U; Jacobsen MB; O'Connor DT; Rønning K; Waldum HL
Neuropeptides; 1994 Mar; 26(3):201-6. PubMed ID: 8208366
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a tumor-derived human pancreastatin-related protein.
Funakoshi S; Tamamura H; Ohta M; Yoshizawa K; Funakoshi A; Miyasaka K; Tateishi K; Tatemoto K; Nakano I; Yajima H
Biochem Biophys Res Commun; 1989 Oct; 164(1):141-8. PubMed ID: 2803289
[TBL] [Abstract][Full Text] [Related]
17. Secretion of pancreastatins from isolated, perfused, porcine adrenal glands.
Jensen TD; Fahrenkrug J; Holst JJ
Peptides; 1994; 15(3):519-27. PubMed ID: 7937328
[TBL] [Abstract][Full Text] [Related]
18. Unique change of pancreastatin-like immunoreactivity in cerebrospinal fluid by aging.
Sekiya K; Nakao R; Takayanagi R; Haji M; Kurose S; Oyama M; Ohashi M; Tateishi K; Funakoshi A; Akazawa K
Neurosci Lett; 1994 Mar; 170(1):179-82. PubMed ID: 8041502
[TBL] [Abstract][Full Text] [Related]
19. Pancreastatin immunoreactivity in favourable childhood neuroblastoma and ganglioneuroma.
Kogner P; Bjellerup P; Svensson T; Theodorsson E
Eur J Cancer; 1995; 31A(4):557-60. PubMed ID: 7576967
[TBL] [Abstract][Full Text] [Related]
20. Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior.
O'Dorisio TM; Krutzik SR; Woltering EA; Lindholm E; Joseph S; Gandolfi AE; Wang YZ; Boudreaux JP; Vinik AI; Go VL; Howe JR; Halfdanarson T; O'Dorisio MS; Mamikunian G
Pancreas; 2010 Jul; 39(5):611-6. PubMed ID: 20124939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
